Abstract:Background: Previous studies have shown that intrahepatic cholestasis of pregnancy (ICP) is associated with an increased incidence of adverse perinatal outcomes, and this supports the contention that ICP is associated with increased risk for both gestational diabetes mellitus (GDM) and preeclampsia. The purpose of this study was to review adverse maternal and perinatal outcomes of ICP in the Chinese population, and to investigate the association between ICP and GDM, as well as between ICP and preeclampsia. Methods: We conducted a retrospective cohort study in which we compared pregnancies affected by ICP with all other deliveries during the study period. Data from women with singleton pregnancies who delivered in 14 representative hospitals in China between October 1, 2016 and September 30, 2017 were collected from our database system. We then performed logistic regression analysis to determine the odds ratios (OR) and 95%CIs of the adverse pregnancy outcomes among women with or without ICP. Results: A total of 95,728 singleton births were induded in the study, and among these, 911 pregnancies were diagnosed as having ICP, resulting in an incidence of 0.95%. Women with ICP were more likely to have GDM [adjusted odds ratio (aOR), 1.406; 95% CI, 1.179-1.677; P<0.001] and preeclampsia (aOR, 2.241; 95% CI, 1.678-2.992; P<0.001) compared with those who did not have ICP. Women in the ICP group exhibited higher rates of scheduled cesarean deliveries (aOR, 3.527; 95% CI, 2.981-4.173; P<0.001) and cesarean deliveries during labor (aOR, 4.388; 95% CI, 1.815-10.612; P=0.027). Women with ICP were also more likely to have iatrogenic preterm delivery (aOR, 2.449; 95% CI, 1.92-3.122; P<0.001) and admission to the neonatal intensive care unit (aOR, 1.572; 95% CI, 1.318-1.874; P<0.001). There was no increased risk of stillbirth in the cohort of ICP cases (aOR, 0.430; 95% CI, 0.049-3.767; P=0.259). Conclusions: ICP was associated with an increased risk of GDM and preeclampsia in singleton pregnancies. Pregnancies with ICP therefore have significantly increased risks of adverse perinatal outcomes.

Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

Intrahepatic cholestasis of pregnancy and maternal dyslipidemia: a systematic review and meta-analysis

Intrahepatic Cholestasis of Pregnancy and Maternal Dyslipidemia: a Systematic Review and Meta‐analysis

The correlation between blood lipids and intrahepatic cholestasis syndrome during pregnancy

Intrahepatic Cholestasis of Pregnancy is Associated with an Increased Risk of Gestational Diabetes and Preeclampsia

LC-MS/MS untargeted lipidomics uncovers placenta lipid signatures from intrahepatic cholestasis of pregnancy

Metabolic Changes in Bile Acids with Pregnancy Progression and Their Correlation with Perinatal Complications in Intrahepatic Cholestasis of Pregnant Patients

Circulatory Metabolomics Reveals the Association of the Metabolites With Clinical Features in the Patients With Intrahepatic Cholestasis of Pregnancy

Altered gene profile of placenta from women with intrahepatic cholestasis of pregnancy

Impaired mixed lymphocyte reaction in intrahepatic cholestasis of pregnancy.

Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study

The Polymorphism of HLA-DR and -DQ Allelic Genes Associated with Intrahepatic Cholestasis of Pregnancy

Genetic study of intrahepatic cholestasis of pregnancy in 101,023 Chinese women unveils East Asian-specific etiology linked to historic HBV infection

Comprehensive Analysis of Quantitative Proteomics With DIA Mass Spectrometry and ceRNA Network in Intrahepatic Cholestasis of Pregnancy

[Influence of Intrahepatic Cholestasis During Pregnancy on the Incidence of Preterm Birth].

Genetic issues in ICP

Placental Gene-Expression Profiles of Intrahepatic Cholestasis of Pregnancy Reveal Involvement of Multiple Molecular Pathways in Blood Vessel Formation and Inflammation

Multidimensional Plasma Lipids Affect Preeclampsia/Eclampsia: A Mendelian Randomization Study

[Maternal-Fetal Mixed Lymphocyte Culture in Intrahepatic Cholestasis of Pregnancy].

The severity of intrahepatic cholestasis during pregnancy increases risks of adverse outcomes beyond stillbirth: evidence from 15,826 patients

Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population